Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. AMGN

Market Cap: $203.66B

AI

Amgen Inc.

AMGN
NASDAQ (NASDAQ Global Select)USD
Purchase AMGN
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin72.65%
EBITDA Margin43.30%
EBIT Margin33.98%
Pre-tax Margin26.98%
Net Profit Margin22.93%
Earnings Yield4.29%
Valuation Multiples
Price / Book17.43
Price / Sales5.34
Price / Earnings23.26
PEG0.73
Forward PEG3.99
EV / Sales6.48
EV / EBITDA14.96
EV / Operating Cash Flow19.79
EV / Free Cash Flow24.27
Price / Free Cash Flow20.02
Price / Operating Cash Flow16.33
Cash Flow & Capital
Free Cash Flow / Share$18.84
Operating Cash Flow / Share$23.11
Free Cash Flow Yield5.00%
Capex / Revenue6.04%
Capex / Operating Cash Flow18.46%
Capex / Depreciation0.94
Stock Compensation / Revenue0.66%
Dividend Payout Ratio60.45%
Dividend Yield2.63%
Liquidity & Leverage
Current Ratio1.37
Quick Ratio1.13
Cash Ratio0.55
Debt / Assets0.60
Debt / Capital0.83
Debt / Equity4.90
Long-Term Debt / Capital0.82
Debt / Market Cap28.14%
Net Debt / EBITDA2.62
Solvency Ratio0.15
Financial Leverage8.18
Efficiency & Working Capital
Asset Turnover0.40
Fixed Asset Turnover4.46
Inventory Turnover1.68
Receivables Turnover3.73
Payables Turnover0.52
Days Sales Outstanding97.91
Days Inventory Outstanding217.73
Days Payables Outstanding702.1
Operating Cycle315.64
Cash Conversion Cycle-386.46
Working Capital Turnover4.77
Returns & Quality
Return on Equity89.32%
Return on Assets9.14%
Return on Invested Capital14.22%
ROCE18.03%
Return on Tangible Assets15.48%
Operating Return on Assets13.45%
Income Quality2.74
Tax Burden0.85
Interest Burden0.79
Balance Sheet & Intrinsic Metrics
Enterprise Value$246.97B
Invested Capital$57.16B
Working Capital$9.46B
Tangible Asset Value$-27.47B
Net Current Asset Value$-48.99B
Graham Number$88.8
Graham Net-Net-$109.6
Book Value / Share$21.64
Tangible Book Value / Share-$50.86
Cash / Share$25.91
Financial Health Scores
Piotroski Score8
Altman Z-Score2.10
Revenue$38.13B
EBIT$12.96B
Market Cap$204.31B
Working Capital$9.46B
Retained Earnings$-22.28B
Total Assets$95.64B
Total Liabilities$83.95B